Good Science and Core_22 WUs
Posted: Sun Jan 05, 2020 1:39 am
Those of you who have been here a while will have seen this with Core_a7 replacing Core_a4.
Core_22 is moving from Beta to Advanced. “Soon” it will be in general release.
Many of you will be frustrated and some of you very much so.
Core_22 does faster Science, and works with the latest AMD GPUs which could not fold with Core_21.
Both the folder volunteers and the researchers at the Universities like better, faster cores. You may think that as soon as there is a stable Core_22, there will be lots of work for it. There won’t be.
Just as we saw with Core_a7 replacing Core_a4, a great deal of WUs are continuations of research already started. Since no researcher is going to throw out his/her existing data, and data using different Cores is not comparable, we may see Core_21 WUs for 3 years.
At first, there will be a trickle of new Core_22 WUs as some researchers have all new Projects they wish to analyze. Over time, the ratio of new projects to continuing projects climbs and in about 3 years those folders who’s GPU does not support Core_22 will complain they have no work.
Again, this should sound familiar to experienced folders. I lost a GPU when Core_11 was replaced by Core_15.
So why will this time be so painful? Owners of AMD DRNA GPUs cannot use Core_21; they will be upset anytime they have no work.
Researchers will start new projects with massive proteins they could not analyze on Core_21. The fastest GPUs for this sort of work are currently by Nvidia. Researchers wanting fast response time, (and they all do) will not want to restrict those cards from using Core_22.
So the best science is going to be done on cards that could do Core_21 WUs, and get lower PPD, while GPUs that can’t do Core_21 will have no work and get 0 PPD. You are saying “Who wins in this scenario?” and the answer is The Researchers. They are in charge and any ‘solution’ that yields slower, less accurate Science will not be approved.
The good news? In 3 years the issue will go away. Meanwhile, do not blame the help on the website, they cannot change these facts.
Core_22 is moving from Beta to Advanced. “Soon” it will be in general release.
Many of you will be frustrated and some of you very much so.
Core_22 does faster Science, and works with the latest AMD GPUs which could not fold with Core_21.
Both the folder volunteers and the researchers at the Universities like better, faster cores. You may think that as soon as there is a stable Core_22, there will be lots of work for it. There won’t be.
Just as we saw with Core_a7 replacing Core_a4, a great deal of WUs are continuations of research already started. Since no researcher is going to throw out his/her existing data, and data using different Cores is not comparable, we may see Core_21 WUs for 3 years.
At first, there will be a trickle of new Core_22 WUs as some researchers have all new Projects they wish to analyze. Over time, the ratio of new projects to continuing projects climbs and in about 3 years those folders who’s GPU does not support Core_22 will complain they have no work.
Again, this should sound familiar to experienced folders. I lost a GPU when Core_11 was replaced by Core_15.
So why will this time be so painful? Owners of AMD DRNA GPUs cannot use Core_21; they will be upset anytime they have no work.
Researchers will start new projects with massive proteins they could not analyze on Core_21. The fastest GPUs for this sort of work are currently by Nvidia. Researchers wanting fast response time, (and they all do) will not want to restrict those cards from using Core_22.
So the best science is going to be done on cards that could do Core_21 WUs, and get lower PPD, while GPUs that can’t do Core_21 will have no work and get 0 PPD. You are saying “Who wins in this scenario?” and the answer is The Researchers. They are in charge and any ‘solution’ that yields slower, less accurate Science will not be approved.
The good news? In 3 years the issue will go away. Meanwhile, do not blame the help on the website, they cannot change these facts.